ConditionPerimenopausal Women
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age40-58
SponsorUniversity of Delaware
About this trial
The purpose of this study is to understand how changes in menopausal hormones like estradiol and follicle-stimulating hormone (FSH) impact sympathetic nervous system function. To do so, the investigators will use a medication to control the production of estradiol and FSH, and in some participants, add-back estradiol to isolate its effects. The investigators will measure sympathetic activation centrally (in the brain using MRI), peripherally in the nervous system, and also examine adrenergic receptor mediated control of vascular function.
Eligibility criteria
Qualifiers
Perimenopausal (based on changes in menstrual cycle)
Ages 40-58 years
Disqualifiers
History of CVD, blood clots, stroke
History of Cancer
History of Liver or Kidney disease
History of Neurological disease
Trial design
Treatments tested in this trial
- Estrogen
- Placebo
Treatment groups
80 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov